Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry Age-Related Macular Degeneration

Joseph R. Abraham, Glenn J. Jaffe, Peter K. Kaiser, Stephanie J. Chiu, Jessica Loo, Sina Farsiu, Laurens Bouckaert, Vicken Karageozian, Melvin Sarayba, Sunil K. Srivastava, Justis P. Ehlers